AI assistant
MEDIFAST INC — Director's Dealing 2023
Jun 20, 2023
33899_dirs_2023-06-20_e0cc59eb-4e00-4147-92e5-2ec847ac5343.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-06-15
Reporting Person: BROWN JEFFREY J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-15 | Common Stock | A | 3289 | — | Acquired | 5681.154 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 37694.873 | Indirect |
| Common Stock | 4069.112 | Indirect |
Footnotes
F1: Represents the right to receive 3,289 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.
F2: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.
F3: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.